That Cytodyn is "seeking ongoing guidance from the U.S. Food and Drug Administration and regulatory agencies in other countries" could mean that Amarex submitted data to the FDA on behalf of Cytodyn while still keeping it blinded to the company. If Cytodyn is looking for an early EUA we'll never know about it unless it gets granted.